Jamjoom Pharma

Jamjoom Pharma has a strong commercial presence with leading positions in ophthalmology and dermatology in Saudi Arabia and the broader Middle East/Africa region. It has been the second most prescribed pharmaceutical manufacturer in Saudi Arabia for several years. The company’s portfolio includes more than 100 branded generic products across 10 therapeutic areas. In 2021 alone it launched 17 new products; its pipeline includes 72 new products with a significant portion submitted or near submission to regulatory authorities[4]. Its flagship brands include Hyfresh for dry eye and Elica cream for skin conditions—both market leaders in their categories within KSA[6].